These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12812909)

  • 1. Does etanercept induce uveitis?
    Reddy AR; Backhouse OC
    Br J Ophthalmol; 2003 Jul; 87(7):925. PubMed ID: 12812909
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept and uveitis: friends or foes?
    Brito-Zerón P; Perez-Alvarez R; Ramos-Casals M;
    Curr Med Res Opin; 2015 Feb; 31(2):251-2. PubMed ID: 25438042
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V; Mergler S; Pleyer U
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.
    Coates LC; McGonagle DG; Bennett AN; Emery P; Marzo-Ortega H
    Ann Rheum Dis; 2008 May; 67(5):729-30. PubMed ID: 18408116
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis following etanercept treatment for ankylosing spondylitis.
    Pfueller CF; Seipelt E; Zipp F; Paul F
    Scand J Rheumatol; 2008; 37(5):397-9. PubMed ID: 18720264
    [No Abstract]   [Full Text] [Related]  

  • 6. Results from an open-label extension study of etanercept in ankylosing spondylitis.
    Davis J; Webb A; Lund S; Sack K
    Arthritis Rheum; 2004 Apr; 51(2):302-4. PubMed ID: 15077279
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapse of sarcoidosis upon treatment with etanercept.
    Louie GH; Chitkara P; Ward MM
    Ann Rheum Dis; 2008 Jun; 67(6):896-8. PubMed ID: 18474661
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can tumor necrosis factor inhibitors induce sclero-uveitis?].
    Le Garrec J; Marcelli C; Mouriaux F
    J Fr Ophtalmol; 2009 Sep; 32(7):511.e1-6. PubMed ID: 19535169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
    Suzuki J; Goto H
    Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of genetic predisposition of de novo uveitis with etanercept in ankylosing spondylitis.
    Killian M; Touraine R; Amouzougan A; Thomas T; Marotte H
    Ann Rheum Dis; 2015 Mar; 74(3):e22. PubMed ID: 25467296
    [No Abstract]   [Full Text] [Related]  

  • 11. Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis.
    Jethwa H; Mann S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myelogenous leukaemia following etanercept therapy.
    Bakland G; Nossent H
    Rheumatology (Oxford); 2003 Jul; 42(7):900-1. PubMed ID: 12826706
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.
    Sieper J; Koenig A; Baumgartner S; Wishneski C; Foehl J; Vlahos B; Freundlich B
    Ann Rheum Dis; 2010 Jan; 69(1):226-9. PubMed ID: 19465402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset psoriasis associated with etanercept therapy.
    Chen LA; Su LH; Chang YJ; Hsu YL; Tsai TH
    J Dermatol; 2010 Apr; 37(4):378-80. PubMed ID: 20507411
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis.
    Martín-Mola E; Sieper J; Leirisalo-Repo M; Dijkmans BA; Vlahos B; Pedersen R; Koenig AS; Freundlich B
    Clin Exp Rheumatol; 2010; 28(2):238-45. PubMed ID: 20483046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of sarcoidosis during etanercept therapy.
    González-López MA; Blanco R; González-Vela MC; Fernández-Llaca H; Rodríguez-Valverde V
    Arthritis Rheum; 2006 Oct; 55(5):817-20. PubMed ID: 17013853
    [No Abstract]   [Full Text] [Related]  

  • 18. Etanercept therapy-associated acute uveitis: a case report and literature review.
    Wang F; Wang NS
    Clin Exp Rheumatol; 2009; 27(5):838-9. PubMed ID: 19917170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demyelination during anti-TNFα therapy for ankylosing spondylitis.
    Mercieca C; Vella N; Borg AA
    Mod Rheumatol; 2012 Apr; 22(2):303-7. PubMed ID: 21748364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.